Pfizer Inc (NYSE: PFE)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 11/15/2024
Closing price: 24.80
Support price level: | N/A |
Resistance price level: | $28.21 |
Relative strength index (14-day RSI) | 15.6 |
Beta | 0.50 |
- PFE is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -17.9 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- PFE is one of this month's worst performers with a return of -15.1%, underperforming 90 percent of stocks in the S&P-100.
- Down 7.2 percent, PFE is one of this week's biggest decliners.
- Volatility is forecast to fall over the next month.
- With RSI < 30, PFE is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$24.80 | $31.39 | 0.0% |
200 day | 50 day | 20 day | 10 day |
$28.15 | $28.64 | $27.66 | $26.73 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
27.2% | 24.7% | 27.7% | 30.1% |
- 7.5% in the next week.
- 17.0% in the next month.
- 49.5% in the next year.
Company news for Pfizer Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks